Not sure if everyone is aware or listens to the conference calls for Acrux? I feel they hold a lot of info that is hard to find and gives a great view of where the company is at. The company seems to post limited updates on product progress which is probably due to the secrecy required for generic product development.
Seems to be a lot of upside considering the share price currently over $5m less than cash backing (as of last half yearly), no debt and a pipeline of products approaching regulatory submission mid 2018...
Would be great if we had updates on the dossier submissions "First dossier planned for submission mid 2018. Other dossiers to follow"
Link below for the interested:
http://www.openbriefing.com/OB/Acru...ar-Results-Investor-Conference-Call/2764.aspx
DYOR
